← Back to Search

Passive Device

wearing the iStride device for Stroke

N/A
Waitlist Available
Led By Kyle B Reed, Ph.D.
Research Sponsored by University of South Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline assessment at start and at conclusion of training
Awards & highlights

Summary

The objective of this research is to test a passive shoe to correct gait in individuals with asymmetric walking patterns. This will be done in a clinic. Individuals with central nervous system damage, such as stroke, often have irregular walking patterns and have difficulty walking correctly. Recent research has shown that using a split-belt treadmill can create after-effects that temporarily correct the inefficient walking patterns. However, the corrected walking pattern does not efficiently transfer from the treadmill to walking over ground. The iStride, formerly known as the Gait Enhancing Mobile Shoe (GEMS), may allow a patient to practice walking in many different locations, such as their own home, which we hypothesize will result in a more permanent transfer of learned gait patterns. To enable long-term use, our proposed shoe design is passive and uses the wearer's natural forces exerted while walking to generate the necessary motions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline assessment at start and at conclusion of training
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline assessment at start and at conclusion of training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage Change in Double Support Asymmetry
Percentage Change in Step Length Asymmetry

Trial Design

1Treatment groups
Experimental Treatment
Group I: wearing the iStride deviceExperimental Treatment1 Intervention
The training will consist of four weeks of training with three training sessions performed each week. The training sessions will consist of up to thirty minutes of training with the iStride on, with breaks between walking sessions and as needed if the subject requests an additional break. Subjects will place the device on their foot in which they have the shortest step length, as measured during the pre-training gait analysis. This is typically the healthy side foot. There will also be several follow up visits following the final testing session.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
wearing the iStride device
2018
N/A
~30

Find a Location

Who is running the clinical trial?

Moterum Technologies, Inc.Industry Sponsor
2 Previous Clinical Trials
29 Total Patients Enrolled
2 Trials studying Stroke
29 Patients Enrolled for Stroke
University of South FloridaLead Sponsor
422 Previous Clinical Trials
189,221 Total Patients Enrolled
4 Trials studying Stroke
165 Patients Enrolled for Stroke
Kyle B Reed, Ph.D.Principal InvestigatorUniversity of South Florida
~1 spots leftby Sep 2025